Summary of Key Points Core Viewpoint - On September 17, 28 Hong Kong-listed companies conducted share buybacks, totaling 16.7684 million shares and an aggregate amount of HKD 649 million [1][2]. Group 1: Share Buyback Details - Tencent Holdings repurchased 839,000 shares for HKD 551 million, with a highest price of HKD 663.50 and a lowest price of HKD 645.50, bringing its total buyback amount for the year to HKD 52.707 billion [1][2]. - Hang Seng Bank repurchased 200,000 shares for HKD 23.8014 million, with a highest price of HKD 119.30 and a lowest price of HKD 118.40, totaling HKD 793 million in buybacks for the year [1][2]. - Pacific Shipping repurchased 6 million shares for HKD 14.9526 million, with a highest price of HKD 2.52 and a lowest price of HKD 2.45, accumulating HKD 203 million in buybacks for the year [1][2]. Group 2: Ranking of Buybacks - The highest buyback amount on September 17 was from Tencent Holdings at HKD 551 million, followed by Hang Seng Bank at HKD 23.8014 million [1][2]. - In terms of share quantity, Pacific Shipping led with 6 million shares repurchased, followed by Linklogis Technology and Weigao Group with 2.3 million and 1.9548 million shares, respectively [1][2]. Group 3: Additional Buyback Information - Other notable companies involved in buybacks include Weigao Group, MGM China, and Jitu Express, with respective buyback amounts of HKD 11.4255 million, HKD 7.873 million, and HKD 7.8348 million [2][3]. - The buyback activity reflects a strategic move by these companies to enhance shareholder value amid market conditions [1][2].

Summary of Key Points Core Viewpoint - Multiple companies, including Tencent Holdings and Hang Seng Bank, conducted share buybacks on September 17, 2025, with Tencent leading in both the number of shares repurchased and the total amount spent. Group 1: Company Buyback Details - Tencent Holdings (00700) repurchased 839,000 shares for a total of 551 million, with a year-to-date total of 58.158 million shares, representing 0.633% of its total share capital [1][2] - Hang Seng Bank (00011) repurchased 200,000 shares for 23.8014 million, with a year-to-date total of 6.93 million shares, representing 0.368% of its total share capital [2] - Pacific Shipping (02343) repurchased 6 million shares for 14.9526 million, with a year-to-date total of 41.006 million shares, representing 0.798% of its total share capital [2] - Weigao Group (01066) repurchased 1.9548 million shares for 11.4255 million, with a year-to-date total of 14.2136 million shares, representing 3.148% of its total share capital [2] - MGM China (02282) repurchased 502,000 shares for 7.873 million, with a year-to-date total of 2.23295 million shares, representing 0.587% of its total share capital [2] Group 2: Other Notable Buybacks - Jitu Express-W (01519) repurchased 870,000 shares for 7.8348 million, with a year-to-date total of 870,000 shares, representing 0.010% of its total share capital [2] - Linkage Technology-W (09959) repurchased 2.3 million shares for 7.4586 million, with a year-to-date total of 19.9075 million shares, representing 0.932% of its total share capital [2] - Mengniu Dairy (02319) repurchased 200,000 shares for 3.074 million, with a year-to-date total of 10.816 million shares, representing 0.276% of its total share capital [2] - China Hongqiao (01378) repurchased 112,500 shares for 2.822 million, with a year-to-date total of 150 million shares, representing 1.610% of its total share capital [2] - Coolpad Group (02369) repurchased 1.348 million shares for 1.8057 million, with a year-to-date total of 23.095 million shares, representing 5.639% of its total share capital [2]

自9月10日以来公司已连续6日进行回购，合计回购45.60万股，累计回购金额1517.29万港元。 其间该股 累计上涨0.21%。 今年以来该股累计进行29次回购，合计回购341.06万股，累计回购金额1.10亿港元。（数据宝） 固生堂回购明细 证券时报·数据宝统计，固生堂在港交所公告显示，9月17日以每股33.360港元至33.800港元的价格回购 13.00万股，回购金额达437.62万港元。该股当日收盘价33.360港元，上涨3.41%，全天成交额1.06亿港 元。 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.09.17 | 13.00 | 33.800 | 33.360 | 437.62 | | 2025.09.16 | 8.17 | 32.400 | 32.120 | 263.96 | | 2025.09.15 | 3.25 | 33.180 | 32.920 | 107. ...

格隆汇9月17日丨固生堂(02273.HK)公告，9月17日耗资437.6万港元回购13万股。 ...

智通财经APP讯，固生堂(02273)发布公告，于2025年9月17日，该公司斥资437.62万港元回购13万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 固生堂控股有限公司 呈交日期： 2025年9月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02273 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前 ...

Core Viewpoint - The recent launch of the "National Medicine AI System" by Guoshengtang demonstrates the company's strategic advancement in integrating AI with traditional Chinese medicine, reinforcing its leadership in the smart healthcare sector [1] Company Developments - Guoshengtang's stock rose by approximately 4.46%, reaching HKD 33.7, with a trading volume of HKD 68.85 million [1] - The company showcased its "Traditional Chinese Medicine + AI" strategy at a conference in Guangzhou, highlighting significant achievements in the field [1] - Management anticipates that AI products will achieve large-scale commercialization by 2025, focusing on four key areas: providing scarce physician resources, training young physicians, enhancing user satisfaction, and accelerating the internationalization of traditional Chinese medicine [1] AI Integration and Services - By June 2025, Guoshengtang plans to launch its first "National Medicine AI Avatar," with a total of 10 AI avatars covering eight core specialties in traditional Chinese medicine by August [1] - The integration of AI technology aims to enhance the supply of quality traditional Chinese medical services, addressing the shortage of high-quality medical resources and providing standardized, efficient diagnostic experiences for patients [1] - The company has also introduced an AI health assistant to further improve the patient experience in diagnosis and treatment [1]

Core Viewpoint - The company, Guoshengtang (02273), has seen a nearly 5% increase in stock price following the launch of its "National Medicine AI System" at a recent conference, highlighting its strategic focus on integrating AI with traditional Chinese medicine [1] Group 1: Company Developments - Guoshengtang's recent conference in Guangzhou showcased the "National Medicine AI System," emphasizing the company's leadership in the intelligentization of traditional Chinese medicine [1] - The management team anticipates that AI products will achieve significant commercial viability by 2025, focusing on four key areas: providing scarce physician resources, training young physicians, enhancing user satisfaction, and accelerating the internationalization of traditional Chinese medicine [1] - By June 2025, Guoshengtang plans to launch its first "National Medicine AI Avatar," with a total of 10 avatars covering eight core specialties in traditional Chinese medicine by August [1] Group 2: Industry Impact - The integration of AI technology into traditional Chinese medicine aims to increase the supply of quality medical services, addressing the shortage of high-quality healthcare resources and providing standardized, efficient diagnostic experiences for more patients [1] - The company has also introduced an AI health assistant to further enhance the patient experience in diagnosis and treatment [1]

格隆汇9月16日丨固生堂(02273.HK)公告，9月16日耗资264万港元回购8.2万股。 ...

固生堂(02273)发布公告，于2025年9月16日该公司斥资263.96万港元回购8.17万股，回购价格为每股 32.12-32.40港元。 ...